• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Whitfield Board Growdon, MD


  • Penson RT, Goodman A, Growdon WB, Borger DR, Lee SI, Oliva E.Case records of the Massachusetts General Hospital. Case 14-2013. A 70-year-old woman with vaginal bleeding.N Engl J Med. 2013 May 9;368(19):1827-35.
  • May T, Shoni M, Vitonis AF, Quick CM, Growdon WB, Muto MG.The role of para-aortic lymphadenectomy in the surgical staging of women with intermediate and high-risk endometrial adenocarcinomas.Int J Surg Oncol. 2013;2013:858916.
  • Dantas PR, Maestá I, Cortés-Charry R, Growdon WB, Braga A, Rudge MV, Berkowitz RS.Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.J Reprod Med.;57(7-8):305-9.
  • Braga A, Growdon WB, Bernstein M, Maestá I, Rudge MV, Goldstein DP, Berkowitz RS.Molar pregnancy in adolescents.J Reprod Med.;57(5-6):225-30.
  • Rauh-Hain JA, Growdon WB, Braga A, Goldstein DP, Berkowitz RS.Gestational trophoblastic neoplasia in adolescents.J Reprod Med.;57(5-6):237-42.
  • Rauh-Hain JA, Winograd D, Growdon WB, Schorge JO, Goodman AK, Boruta DM, Berkowitz RS, Horowitz NS, Del Carmen MG.Prognostic determinants in patients with uterine and ovarian clear carcinoma.Gynecol Oncol. 2012 Feb 21.
  • Growdon WB, Rauh-Hain JJ, Cordon A, Garrett L, Schorge JO, Goodman A, Boruta DM, Horowitz NS, Del Carmen MG.Prognostic determinants in patients with stage I uterine papillary serous carcinoma: a 15-year multi-institutional review.Int J Gynecol Cancer. 2012 Mar;22(3):417-24.
  • Engler DA, Gupta S, Growdon WB, Drapkin RI, Nitta M, Sergent PA, Allred SF, Gross J, Deavers MT, Kuo WL, Karlan BY, Rueda BR, Orsulic S, Gershenson DM, Birrer MJ, Gray JW, Mohapatra G.Genome wide DNA copy number analysis of serous type ovarian carcinomas identifies genetic markers predictive of clinical outcome.PLoS ONE. 2012;7(2):e30996.
  • Weber S, McCann CK, Boruta DM, Schorge JO, Growdon WB.Laparoscopic surgical staging of early ovarian cancer.Rev Obstet Gynecol. 2011;4(3-4):117-22.
  • Growdon WB.Age and postmenopausal bleeding risk factors for malignant changes in endometrial polyps.Menopause. 2011 Dec;18(12):1267.
  • McCann CK, Growdon WB, Kulkarni-Datar K, Curley MD, Friel AM, Proctor JL, Sheikh H, Deyneko I, Ferguson JA, Vathipadiekal V, Birrer MJ, Borger DR, Mohapatra G, Zukerberg LR, Foster R, Macdougall JR, Rueda BR.Inhibition of Hedgehog signaling antagonizes serous ovarian cancer growth in a primary xenograft model.PLoS ONE. 2011;6(11):e28077.
  • Rauh-Hain JA, Rodriguez N, Growdon WB, Goodman AK, Boruta DM, Horowitz NS, Del Carmen MG, Schorge JO.Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer.Ann Surg Oncol. 2011 Oct 13.
  • Boruta DM, Growdon WB, McCann CK, Garrett LA, Del Carmen MG, Goodman A, Schorge JO.Evolution of surgical management of early-stage endometrial cancer.Am J Obstet Gynecol. 2011 Jun 29.
  • Esselen KM, Boruta DM, Del Carmen M, Schorge JO, Goodman A, Growdon WB.Defining prognostic variables in recurrent endometrioid endometrial cancer: a 15-year single-institution review.Int J Gynecol Cancer. 2011 Aug;21(6):1078-83.
  • Growdon WB, Roussel BN, Scialabba VL, Foster R, Dias-Santagata D, Iafrate AJ, Ellisen LW, Tambouret RH, Rueda BR, Borger DR.Tissue-specific signatures of activating PIK3CA and RAS mutations in carcinosarcomas of gynecologic origin.Gynecol Oncol. 2011 Apr;121(1):212-7.
  • McCann CK, Growdon WB, Munro EG, Del Carmen MG, Boruta DM, Schorge JO, Goodman A.Prognostic Significance of Splenectomy as Part of Initial Cytoreductive Surgery in Ovarian Cancer.Ann Surg Oncol. 2011 Mar 22.
  • Rauh-Hain JA, Growdon WB, Schorge JO, Goodman AK, Boruta DM, McCann C, Horowitz NS, del Carmen MG.Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma.Gynecol Oncol. 2010 Nov;119(2):299-304.
  • Friel AM, Growdon WB, McCann CK, Olawaiye AB, Munro EG, Schorge JO, Castrillon DH, Broaddus RR, Rueda BR.Mouse models of uterine corpus tumors: clinical significance and utility.Front Biosci (Elite Ed). 2010;2:882-905. Review.
  • Growdon WB,Boisvert SL,Akhavanfard S,Oliva E,Dias-Santagata DC,Kojiro S,Horowitz NS,Iafrate AJ,Borger DR,Rueda BR.Decreased survival in EGFR gene amplified vulvar carcinoma.Gynecol Oncol. 2008 Nov;111(2):289-97.